Pacing, Defibrillators & Cardiac Resynchronisation Therapy

Category icon
Cardiac Resynchronisation Therapy and Cellular Bioenergetics

Christos-Konstantinos Antoniou, Panagiota Manolakou, Nikolaos Magkas, et al

Category icon
A Risk Score to Predict the Absence of Left Ventricular Reverse…

Jordi Perez-Rodon, Enrique Galve, Carmen Pérez-Bocanegra, et al

Category icon
Cardiac Resynchronization is Associated with Reduction in the Rate of ICD…

Gerard Oristrell, Enrique Galve, Juan Gabriel Acosta, et al

Category icon
18F-FDG-PET/CT Scanning and Lead Endocarditis

Sana Amraoui, Ghoufrane Tlili, Elif Hindié, et al

Category icon
Sudden Cardiac Death in Athletes

Andrew D’Silva, Michael Papadakis,

Category icon
Risk Stratification in Hypertrophic Cardiomyopathy

Alexandros Klavdios Steriotis, Sanjay Sharma,

Category icon
Syncope in the Elderly

Helen O’Brien, Rose Anne Kenny,

Category icon
Foreword

Frank Grothues,

About

Cardiac pacing is a well-established therapeutic tool improving the survival and quality of life in patients. Indications for permanent cardiac pacing include sinus node dysfunction, intermittent and incomplete atrioventricular block, and bundle branch block.

Cardiac pacing, in conjunction with beta-blocker therapy, can potentially reduce the risk of bradycardia-dependent QT prolongation, decrease heart-rate irregularities and reduce repolarisation heterogeneity.

Cardiac resynchronisation therapy (CRT) with biventricular pacing is an effective therapy in patients with advanced heart failure (HF) – New York Heart Association (NYHA) Class III or IV, an ejection fraction (EF) 120 ms.

CRT has also been shown to be effective for the prevention of HF in relatively asymptomatic patients with wide QRS. However, CRT is underutilised among eligible patients. Approximately one-third of patients do not respond to CRT due to various factors, including anatomic difficulties and suboptimal lead placement. To increase the effectiveness of CRT, it has been hypothesised that pacing at multiple left ventricular (LV) sites may provide more effective resynchronisation.

In clinical studies, use of MultiPoint pacing in HF patients undergoing CRT has been associated with increased haemodynamic and clinical benefits compared with conventional pacing, particularly in patients with the least improvement from biventricular pacing.

Related Articles

Articles

Article icon
Heart Failure Treatment by Device

Antoni Bayés-Genís,

Published:

Citation: European Cardiology Review 2020;15:e17.

Cardiac Resynchronisation Therapy and Cellular Bioenergetics

Christos-Konstantinos Antoniou, Panagiota Manolakou, Nikolaos Magkas,

Published:

Citation: European Cardiology Review 2019;14(1):33–44

A Risk Score to Predict the Absence of Left Ventricular Reverse…

Jordi Perez-Rodon, Enrique Galve, Carmen Pérez-Bocanegra,

Citation: European Cardiology Review 2017;12(2):99.

Cardiac Resynchronization is Associated with Reduction in the Rate of ICD…

Gerard Oristrell, Enrique Galve, Juan Gabriel Acosta,

Citation: European Cardiology Review 2017;12(2):93.